# Novartis Pharmaceuticals Corporation, Morris Plains, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47

> Inspection records and compliance data for Novartis Pharmaceuticals Corporation in Morris Plains, NJ. 5 FDA inspections on record, 3 Form 483s, last inspected February 06, 2026.

---

## Details

- Name: Novartis Pharmaceuticals Corporation
- FEI Number: 3010353512
- Address Line 1: 220 East Hanover Ave.
- City: Morris Plains
- State: NJ
- Zip Code: 07950
- Country Name: United States
- Address: 220 East Hanover Ave., Morris Plains, NJ 07950, United States
- Country: United States

## Related Documents

- [483 - Novartis Pharmaceuticals Corporation - Unknown Date](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/c31e1262-2601-41e1-b055-114f96464537) — source: FDA, date: Invalid Date
- [483 - Novartis Pharmaceuticals Corporation - 2026-02-06](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/5f685210-dc63-45e1-8c77-efd089d4eafb) — source: FDA, date: February 6, 2026
- [FDA Inspection 1300144 - Novartis Pharmaceuticals Corporation - 2026-02-06](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/dda9986d-7403-4915-9abe-66007c22736d) — source: FDA, date: February 6, 2026
- [483 - Novartis Pharmaceuticals Corporation - 2024-08-08](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/44e0cb23-0ec8-4334-bb8c-6f66a38965a7) — source: FDA, date: August 8, 2024
- [FDA Inspection 1245942 - Novartis Pharmaceuticals Corporation - 2024-08-08](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/d2f19248-2be2-424d-85b3-a50251928268) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 8, 2024
- [UNTITLED_LETTER - Novartis Pharmaceuticals Corporation - 2023-08-08](https://www.keypedia.com/records/untitled_letter/novartis-pharmaceuticals-corporation/cd26624a-3912-48a5-979f-444b80110332) — source: FDA, date: August 8, 2023
- [483 - Novartis Pharmaceuticals Corporation - 2022-12-09](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/b1680319-d6ed-404f-97d8-29d30a5966c6) — source: FDA, date: December 9, 2022
- FDA Inspection 1194474 - Novartis Pharmaceuticals Corporation - 2022-12-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2022
- FDA Inspection 1194474 - Novartis Pharmaceuticals Corporation - 2022-12-09 — classification: No Action Indicated (NAI), source: FDA, date: December 9, 2022
- [EIR - Novartis Pharmaceuticals Corporation - 2019-08-21](https://www.keypedia.com/records/eir/novartis-pharmaceuticals-corporation/43fb0c26-6023-4fdb-a1bf-b32b89a06cda) — source: FDA, date: August 21, 2019
- [483 - Novartis Pharmaceuticals Corporation - 2019-08-21](https://www.keypedia.com/records/483/novartis-pharmaceuticals-corporation/46e237ea-aa74-4167-91ef-3f93ae6e17f4) — source: FDA, date: August 21, 2019
- [FDA Inspection 1100101 - Novartis Pharmaceuticals Corporation - 2019-08-21](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 21, 2019
- [EIR - Novartis Pharmaceuticals Corporation - 2017-04-07](https://www.keypedia.com/records/eir/novartis-pharmaceuticals-corporation/dc811ce0-15ca-4574-b458-2033e9d22993) — source: FDA, date: April 7, 2017
- [FDA Inspection 1019194 - Novartis Pharmaceuticals Corporation - 2017-04-07](https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-corporation/9ab30769-64e6-41c7-bcc0-e04710bf5034) — source: FDA, date: April 7, 2017

## Related Companies

- [Kite Pharma, Inc.](https://www.keypedia.com/companies/kite-pharma-inc/5bf88060-db53-466b-9a1c-85be7984894f)
- [Emergent Biodefense Operations Lansing LLC](https://www.keypedia.com/companies/emergent-biodefense-operations-lansing-llc/7a502584-4071-4f7a-bb11-7272db98f478)
- [Charles River Laboratories Inc](https://www.keypedia.com/companies/charles-river-laboratories-inc/876b68d9-6285-4039-8732-05f876b5d911)
- [Seqirus Inc](https://www.keypedia.com/companies/seqirus-inc/0debebe6-6f57-40d3-abf9-5914fb18b58a)
- [Dendreon Pharmaceuticals LLC](https://www.keypedia.com/companies/dendreon-pharmaceuticals-llc/3de4a8e5-8e34-4212-8862-ecd5256c6ffe)
- [Autolus Limited](https://www.keypedia.com/companies/autolus-limited/1961ca64-40e0-44c3-a789-bc25ce1244c2)
- [Roslin Cell Therapies Limited](https://www.keypedia.com/companies/roslin-cell-therapies-limited/284a8034-03ae-4031-906d-7603e297f7ab)
- [FinVector Oy](https://www.keypedia.com/companies/finvector-oy/880a8467-a5a4-431b-b597-7dd6e59b185b)
- [Lonza Houston, Inc](https://www.keypedia.com/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6)
- [MassBiologics](https://www.keypedia.com/companies/massbiologics/fa584e7c-22de-470c-836a-dd3028fae600)

## Related Officers

- [Biologist](https://www.keypedia.com/people/xiaobin-victor-lu/301d14d8-0252-484a-b363-8349b3ad3a80)
- [Joan Johnson](https://www.keypedia.com/people/joan-johnson/5da1159e-453c-49a1-8e6d-5fa6b9fb0352)
- [investigator](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)
- [Colleen Hoyt](https://www.keypedia.com/people/colleen-hoyt/2a9c0d42-46de-4c53-820f-64468eb3e608)
- [investigator](https://www.keypedia.com/people/kimberly-l-schultz/2d000290-f49c-4cfd-b8f8-3f4d71f76324)
- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)